


874 F.3d 724
United States Court of Appeals, Federal Circuit.
MERCK SHARP & DOHME CORP., Plaintiff-Appellant
v.
HOSPIRA, INC., Defendant-Appellee
2017-1115
|
Decided: October 26, 2017
Synopsis
Background: Owner of patents directed to a process for preparing a stable formulation of ertapenem, an antibiotic compound, brought infringement action against competitor. Following bench trial, the United States District Court for the District of Delaware, Nos. 1:14-cv-00915-RGA, 1:14-cv-00916-RGA, Richard G. Andrews, J., 2016 WL 5872620, entered finding of obviousness and invalidity. Patent owner appealed.
 
Holdings: The Court of Appeals, Lourie, Circuit Judge, held that:
 
claimed process would have been obvious at the time invention was made, and
 
secondary considerations did not overcome finding of obviousness.
 
Affirmed.
 
Newman, Circuit Judge, filed a dissenting opinion.
 
*725 Appeal from the United States District Court for the District of Delaware in Nos. 1:14-cv-00915-RGA, 1:14-cv-00916-RGA, Judge Richard G. Andrews.
